Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Apimeds Pharmaceuticals US, Inc. Share Price

APUS

ASQ

$1.23

+$0.13

(11.82%)

Industry: Capital Markets Sector: Financials

Apimeds Pharmaceuticals US, Inc. Analyst Forecast

Overview Returns Financials Ratios News FAQs

Apimeds Pharmaceuticals US, Inc. Share Price Chart

Apimeds Pharmaceuticals US, Inc. Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$13.83M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

161.79K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$1.05 L

$4.03 H

$1.23

About Apimeds Pharmaceuticals US, Inc., Common Stock

Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company is based in Ras al-Khaimah, the United Arab Emirates. more

Industry: Capital MarketsSector: Financials

Apimeds Pharmaceuticals US, Inc. Stock Returns

Time Frame	APUS	Sector	S&P500
1-Week Return	-32.1%	-4.74%	-1.38%
1-Month Return	-35.67%	-4.68%	-1.81%
3-Month Return	-60.57%	-2.43%	1.38%
6-Month Return	-32.1%	-2.03%	5.68%
1-Year Return	-50%	-0.02%	11.74%

Time Frame	APUS	Sector	S&P500
1-Week Return	-100.00%	-92.05%	-51.55%
1-Month Return	-99.53%	-44.19%	-19.93%
3-Month Return	-97.70%	-9.50%	5.72%
6-Month Return	-54.39%	-4.07%	11.85%
1-Year Return	-50.00%	-0.02%	11.74%

Apimeds Pharmaceuticals US, Inc. Financials

	Dec '21	Dec '22	Dec '23	Dec '24
Total Revenue	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	1.02M	639.53K	747.44K	1.28M	[{"date":"2021-12-31","value":79.95,"profit":true},{"date":"2022-12-31","value":50.16,"profit":true},{"date":"2023-12-31","value":58.62,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	(1.02M)	(639.53K)	(747.44K)	(1.28M)	[{"date":"2021-12-31","value":-101949400,"profit":false},{"date":"2022-12-31","value":-63952900,"profit":false},{"date":"2023-12-31","value":-74743600,"profit":false},{"date":"2024-12-31","value":-127509500,"profit":false}]
Total Non-Operating Income/Expense	(13.48K)	(58.27K)	(60.52K)	(229.79K)	[{"date":"2021-12-31","value":-1348000,"profit":false},{"date":"2022-12-31","value":-5827400,"profit":false},{"date":"2023-12-31","value":-6051600,"profit":false},{"date":"2024-12-31","value":-22979000,"profit":false}]
Pre-Tax Income	(1.03M)	(668.67K)	(777.69K)	(1.39M)	[{"date":"2021-12-31","value":-102623400,"profit":false},{"date":"2022-12-31","value":-66866600,"profit":false},{"date":"2023-12-31","value":-77769400,"profit":false},{"date":"2024-12-31","value":-138999000,"profit":false}]
Income Taxes	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	(1.03M)	(668.67K)	(777.69K)	(1.39M)	[{"date":"2021-12-31","value":-102623400,"profit":false},{"date":"2022-12-31","value":-66866600,"profit":false},{"date":"2023-12-31","value":-77769400,"profit":false},{"date":"2024-12-31","value":-138999000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(1.03M)	(668.67K)	(777.69K)	(1.39M)	[{"date":"2021-12-31","value":-102623400,"profit":false},{"date":"2022-12-31","value":-66866600,"profit":false},{"date":"2023-12-31","value":-77769400,"profit":false},{"date":"2024-12-31","value":-138999000,"profit":false}]

EPS (Diluted)	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

	Dec '21	Dec '22	Dec '23	Dec '24
Total Revenue	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	-	(37.27%)	16.87%	70.60%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-52.79,"profit":false},{"date":"2023-12-31","value":23.9,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	-	(37.27%)	16.87%	70.60%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-52.79,"profit":false},{"date":"2023-12-31","value":23.9,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	332.30%	3.85%	279.72%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":1.16,"profit":true},{"date":"2024-12-31","value":84.18,"profit":true}]
Pre-Tax Income	-	(34.84%)	16.31%	78.73%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-44.25,"profit":false},{"date":"2023-12-31","value":20.71,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	(34.84%)	16.31%	78.73%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-44.25,"profit":false},{"date":"2023-12-31","value":20.71,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	(34.84%)	16.31%	78.73%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-44.25,"profit":false},{"date":"2023-12-31","value":20.71,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

EPS (Diluted)	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Cost of Revenue	-	-	-	-	1.49K	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Gross Profit	-	-	-	-	(1.49K)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":-148900,"profit":false}]
Gross Margin	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Operating Expenses	300.00K	275.61K	364.37K	2.66M	1.84M	[{"date":"2024-09-30","value":11.26,"profit":true},{"date":"2024-12-31","value":10.35,"profit":true},{"date":"2025-03-31","value":13.68,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":69.17,"profit":true}]
Operating Income	(300.00K)	(275.61K)	(364.37K)	(2.66M)	(1.84M)	[{"date":"2024-09-30","value":-29999900,"profit":false},{"date":"2024-12-31","value":-27561300,"profit":false},{"date":"2025-03-31","value":-36436800,"profit":false},{"date":"2025-06-30","value":-266390400,"profit":false},{"date":"2025-09-30","value":-184423900,"profit":false}]
Total Non-Operating Income/Expense	(65.04K)	(72.04K)	(76.06K)	(6.10K)	113.11K	[{"date":"2024-09-30","value":-57.51,"profit":false},{"date":"2024-12-31","value":-63.69,"profit":false},{"date":"2025-03-31","value":-67.24,"profit":false},{"date":"2025-06-30","value":-5.39,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Pre-Tax Income	(332.52K)	(311.63K)	(402.40K)	(2.66M)	(1.78M)	[{"date":"2024-09-30","value":-33252100,"profit":false},{"date":"2024-12-31","value":-31163300,"profit":false},{"date":"2025-03-31","value":-40239700,"profit":false},{"date":"2025-06-30","value":-266219300,"profit":false},{"date":"2025-09-30","value":-178125500,"profit":false}]
Income Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Income After Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	(332.52K)	(311.63K)	(402.40K)	(2.66M)	(1.78M)	[{"date":"2024-09-30","value":-33252100,"profit":false},{"date":"2024-12-31","value":-31163300,"profit":false},{"date":"2025-03-31","value":-40239700,"profit":false},{"date":"2025-06-30","value":-266219300,"profit":false},{"date":"2025-09-30","value":-178125500,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	(332.52K)	(311.63K)	(402.40K)	(2.66M)	(1.78M)	[{"date":"2024-09-30","value":-33252100,"profit":false},{"date":"2024-12-31","value":-31163300,"profit":false},{"date":"2025-03-31","value":-40239700,"profit":false},{"date":"2025-06-30","value":-266219300,"profit":false},{"date":"2025-09-30","value":-178125500,"profit":false}]

EPS (Diluted)	-	-	(0.04)	(0.26)	(0.14)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-4,"profit":false},{"date":"2025-06-30","value":-26,"profit":false},{"date":"2025-09-30","value":-14,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Cost of Revenue	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Gross Profit	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Gross Margin	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Operating Expenses	-	(8.13%)	32.20%	631.10%	(30.83%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-1.29,"profit":false},{"date":"2025-03-31","value":5.1,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-4.88,"profit":false}]
Operating Income	-	(8.13%)	32.20%	631.10%	(30.77%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-1.29,"profit":false},{"date":"2025-03-31","value":5.1,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-4.88,"profit":false}]
Total Non-Operating Income/Expense	-	10.76%	5.58%	(91.99%)	(1955.46%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":51.86,"profit":true},{"date":"2025-06-30","value":-855.21,"profit":false},{"date":"2025-09-30","value":-18180.55,"profit":false}]
Pre-Tax Income	-	(6.28%)	29.13%	561.58%	(33.09%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-1.12,"profit":false},{"date":"2025-03-31","value":5.19,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-5.89,"profit":false}]
Income Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Income After Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	-	(6.28%)	29.13%	561.58%	(33.09%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-1.12,"profit":false},{"date":"2025-03-31","value":5.19,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-5.89,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	(6.28%)	29.13%	561.58%	(33.09%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-1.12,"profit":false},{"date":"2025-03-31","value":5.19,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-5.89,"profit":false}]

EPS (Diluted)	-	-	-	550.00%	(46.15%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-8.39,"profit":false}]

	Dec '21	Dec '22	Dec '23	Dec '24
Total Assets
Current Assets	172.17K	6.17K	422.08K	13.06K	[{"date":"2021-12-31","value":40.79,"profit":true},{"date":"2022-12-31","value":1.46,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":3.09,"profit":true}]
Non-current Assets	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Assets	172.17K	6.17K	422.08K	13.06K	[{"date":"2021-12-31","value":40.79,"profit":true},{"date":"2022-12-31","value":1.46,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":3.09,"profit":true}]

Total Liabilities
Current Liabilities	10.65K	319.78K	123.31K	1.02M	[{"date":"2021-12-31","value":1.04,"profit":true},{"date":"2022-12-31","value":31.22,"profit":true},{"date":"2023-12-31","value":12.04,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	400.00K	400.00K	266.89K	346.84K	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":66.72,"profit":true},{"date":"2024-12-31","value":86.71,"profit":true}]
Total Liabilities	410.65K	719.78K	390.20K	1.37M	[{"date":"2021-12-31","value":29.95,"profit":true},{"date":"2022-12-31","value":52.49,"profit":true},{"date":"2023-12-31","value":28.46,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	100.00K	100.00K	205.50K	79.04K	[{"date":"2021-12-31","value":48.66,"profit":true},{"date":"2022-12-31","value":48.66,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":38.46,"profit":true}]
Retained Earnings	(1.56M)	(2.22M)	(3.00M)	(4.39M)	[{"date":"2021-12-31","value":-155557400,"profit":false},{"date":"2022-12-31","value":-222424000,"profit":false},{"date":"2023-12-31","value":-300193400,"profit":false},{"date":"2024-12-31","value":-439192400,"profit":false}]
Other Stockholders' Equity	1.22M	1.41M	2.83M	2.95M	[{"date":"2021-12-31","value":41.19,"profit":true},{"date":"2022-12-31","value":47.74,"profit":true},{"date":"2023-12-31","value":95.72,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	(238.48K)	(713.61K)	31.87K	(1.36M)	[{"date":"2021-12-31","value":-748.28,"profit":false},{"date":"2022-12-31","value":-2239.04,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-4261.31,"profit":false}]

Total Liabilities & Shareholders Equity	172.17K	6.17K	422.08K	13.06K	[{"date":"2021-12-31","value":40.79,"profit":true},{"date":"2022-12-31","value":1.46,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":3.09,"profit":true}]

	Dec '21	Dec '22	Dec '23	Dec '24
Total Assets
Current Assets	-	(96.42%)	6739.67%	(96.91%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-1.43,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-1.44,"profit":false}]
Non-current Assets	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Assets	-	(96.42%)	6739.67%	(96.91%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-1.43,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-1.44,"profit":false}]

Total Liabilities
Current Liabilities	-	2902.04%	(61.44%)	730.67%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-2.12,"profit":false},{"date":"2024-12-31","value":25.18,"profit":true}]
Non-current Liabilities	-	-	(33.28%)	29.96%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-111.08,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Total Liabilities	-	75.28%	(45.79%)	251.40%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":29.94,"profit":true},{"date":"2023-12-31","value":-18.21,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	105.50%	(61.54%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-58.33,"profit":false}]
Retained Earnings	-	42.99%	34.96%	46.30%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":92.83,"profit":true},{"date":"2023-12-31","value":75.51,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Other Stockholders' Equity	-	15.90%	100.50%	4.47%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":15.82,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":4.45,"profit":true}]
Total Shareholders' equity	-	199.23%	(104.47%)	(4361.31%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-52.44,"profit":false},{"date":"2024-12-31","value":-2189.11,"profit":false}]

Total Liabilities & Shareholders Equity	-	(96.42%)	6739.67%	(96.91%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-1.43,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-1.44,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	36.91K	13.06K	259.90K	10.35M	9.09M	[{"date":"2024-09-30","value":0.36,"profit":true},{"date":"2024-12-31","value":0.13,"profit":true},{"date":"2025-03-31","value":2.51,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":87.79,"profit":true}]
Non-current Assets	-	-	-	197.13K	163.93K	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":83.16,"profit":true}]
Total Assets	36.91K	13.06K	259.90K	10.55M	9.25M	[{"date":"2024-09-30","value":0.35,"profit":true},{"date":"2024-12-31","value":0.12,"profit":true},{"date":"2025-03-31","value":2.46,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":87.71,"profit":true}]

Total Liabilities
Current Liabilities	761.40K	1.02M	1.77M	809.00K	1.09M	[{"date":"2024-09-30","value":43.01,"profit":true},{"date":"2024-12-31","value":57.86,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":45.7,"profit":true},{"date":"2025-09-30","value":61.53,"profit":true}]
Non-current Liabilities	321.99K	346.84K	250.00K	-	-	[{"date":"2024-09-30","value":92.83,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":72.08,"profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Total Liabilities	1.08M	1.37M	2.02M	809.00K	1.09M	[{"date":"2024-09-30","value":53.62,"profit":true},{"date":"2024-12-31","value":67.87,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":40.04,"profit":true},{"date":"2025-09-30","value":53.92,"profit":true}]

Total Shareholders' equity
Common Stock	205.50K	79.04K	79.04K	125.76K	125.76K	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":38.46,"profit":true},{"date":"2025-03-31","value":38.46,"profit":true},{"date":"2025-06-30","value":61.2,"profit":true},{"date":"2025-09-30","value":61.2,"profit":true}]
Retained Earnings	(4.08M)	(4.39M)	(4.79M)	(7.46M)	(9.24M)	[{"date":"2024-09-30","value":-408029100,"profit":false},{"date":"2024-12-31","value":-439192400,"profit":false},{"date":"2025-03-31","value":-479432100,"profit":false},{"date":"2025-06-30","value":-745651400,"profit":false},{"date":"2025-09-30","value":-923776900,"profit":false}]
Other Stockholders' Equity	2.83M	2.95M	2.95M	17.07M	17.27M	[{"date":"2024-09-30","value":16.37,"profit":true},{"date":"2024-12-31","value":17.11,"profit":true},{"date":"2025-03-31","value":17.11,"profit":true},{"date":"2025-06-30","value":98.82,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	(1.05M)	(1.36M)	(1.76M)	9.74M	8.16M	[{"date":"2024-09-30","value":-10.75,"profit":false},{"date":"2024-12-31","value":-13.95,"profit":false},{"date":"2025-03-31","value":-18.08,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":83.8,"profit":true}]

Total Liabilities & Shareholders Equity	36.91K	13.06K	259.90K	10.55M	9.25M	[{"date":"2024-09-30","value":0.35,"profit":true},{"date":"2024-12-31","value":0.12,"profit":true},{"date":"2025-03-31","value":2.46,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":87.71,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	(64.62%)	1890.53%	3882.07%	(12.21%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-1.66,"profit":false},{"date":"2025-03-31","value":48.7,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-0.31,"profit":false}]
Non-current Assets	-	-	-	-	(16.84%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":null,"profit":false}]
Total Assets	-	(64.62%)	1890.53%	3957.91%	(12.29%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-1.63,"profit":false},{"date":"2025-03-31","value":47.77,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-0.31,"profit":false}]

Total Liabilities
Current Liabilities	-	34.53%	72.84%	(54.30%)	34.66%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":47.41,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-74.56,"profit":false},{"date":"2025-09-30","value":47.58,"profit":true}]
Non-current Liabilities	-	7.72%	(27.92%)	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-361.76,"profit":false},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Total Liabilities	-	26.56%	47.35%	(59.96%)	34.66%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":56.1,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-126.63,"profit":false},{"date":"2025-09-30","value":73.2,"profit":true}]

Total Shareholders' equity
Common Stock	-	(61.54%)	-	59.11%	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-104.11,"profit":false},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Retained Earnings	-	7.64%	9.16%	55.53%	23.89%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":13.75,"profit":true},{"date":"2025-03-31","value":16.5,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":43.02,"profit":true}]
Other Stockholders' Equity	-	4.47%	-	477.66%	1.20%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":0.94,"profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":0.25,"profit":true}]
Total Shareholders' equity	-	29.78%	29.63%	(653.11%)	(16.20%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":99.5,"profit":true},{"date":"2025-06-30","value":-2193.19,"profit":false},{"date":"2025-09-30","value":-54.38,"profit":false}]

Total Liabilities & Shareholders Equity	-	(64.62%)	1890.53%	3957.91%	(12.29%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-1.63,"profit":false},{"date":"2025-03-31","value":47.77,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-0.31,"profit":false}]

	Dec '21	Dec '22	Dec '23	Dec '24
Operating Activities
Net Operating Cash Flow	(823.11K)	(448.17K)	(627.79K)	(733.53K)	[{"date":"2021-12-31","value":-82311400,"profit":false},{"date":"2022-12-31","value":-44816700,"profit":false},{"date":"2023-12-31","value":-62779000,"profit":false},{"date":"2024-12-31","value":-73352600,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	400.00K	282.90K	1.03M	326.50K	[{"date":"2021-12-31","value":38.76,"profit":true},{"date":"2022-12-31","value":27.41,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":31.63,"profit":true}]

Net Change in Cash	(423.11K)	(165.27K)	404.31K	(407.03K)	[{"date":"2021-12-31","value":-104.65,"profit":false},{"date":"2022-12-31","value":-40.88,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-100.67,"profit":false}]

Free Cash Flow
Free Cash Flow	(823.11K)	(448.17K)	(627.79K)	(733.53K)	[{"date":"2021-12-31","value":-82311400,"profit":false},{"date":"2022-12-31","value":-44816700,"profit":false},{"date":"2023-12-31","value":-62779000,"profit":false},{"date":"2024-12-31","value":-73352600,"profit":false}]

	Dec '21	Dec '22	Dec '23	Dec '24
Operating Activities
Net Operating Cash Flow	-	(45.55%)	40.08%	16.84%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-113.65,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":42.02,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	(29.28%)	264.83%	(68.37%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-11.05,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-25.81,"profit":false}]

Net Change in Cash	-	(60.94%)	(344.64%)	(200.67%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(45.55%)	40.08%	16.84%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-113.65,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":42.02,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	(186.75K)	(99.62K)	(20.31K)	(3.36M)	(1.73M)	[{"date":"2024-09-30","value":-18675500,"profit":false},{"date":"2024-12-31","value":-9961600,"profit":false},{"date":"2025-03-31","value":-2031300,"profit":false},{"date":"2025-06-30","value":-336109600,"profit":false},{"date":"2025-09-30","value":-172616600,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	-	(13.37K)	(22.54K)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":-1336900,"profit":false},{"date":"2025-09-30","value":-2254000,"profit":false}]

Financing Activities
Net Financing Cash Flow	150.00K	76.50K	267.20K	11.86M	-	[{"date":"2024-09-30","value":1.26,"profit":true},{"date":"2024-12-31","value":0.65,"profit":true},{"date":"2025-03-31","value":2.25,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Net Change in Cash	(36.76K)	(23.12K)	246.89K	8.48M	(1.75M)	[{"date":"2024-09-30","value":-0.43,"profit":false},{"date":"2024-12-31","value":-0.27,"profit":false},{"date":"2025-03-31","value":2.91,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-20.61,"profit":false}]

Free Cash Flow
Free Cash Flow	(186.75K)	(99.62K)	(20.31K)	(3.37M)	(1.75M)	[{"date":"2024-09-30","value":-18675500,"profit":false},{"date":"2024-12-31","value":-9961600,"profit":false},{"date":"2025-03-31","value":-2031300,"profit":false},{"date":"2025-06-30","value":-337446000,"profit":false},{"date":"2025-09-30","value":-174871000,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	(46.66%)	(79.61%)	16446.53%	(48.64%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-0.28,"profit":false},{"date":"2025-03-31","value":-0.48,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-0.3,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	-	-	68.60%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Financing Activities
Net Financing Cash Flow	-	(49.00%)	249.28%	4338.42%	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-1.13,"profit":false},{"date":"2025-03-31","value":5.75,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Net Change in Cash	-	(37.11%)	(1168.04%)	3336.79%	(120.61%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-1.11,"profit":false},{"date":"2025-03-31","value":-35,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-3.61,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(46.66%)	(79.61%)	16512.32%	(48.18%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-0.28,"profit":false},{"date":"2025-03-31","value":-0.48,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-0.29,"profit":false}]

Apimeds Pharmaceuticals US, Inc. Ratios

Apimeds Pharmaceuticals US, Inc. Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	APUS
Cash Ratio	6.41
Current Ratio	8.34

Apimeds Pharmaceuticals US, Inc. Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	APUS
ROA (LTM)	-409.38%
ROE (LTM)	0.00%

Apimeds Pharmaceuticals US, Inc. Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	APUS
Debt Ratio Lower is generally better. Negative is bad.	0.12
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.88

Apimeds Pharmaceuticals US, Inc. Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	APUS
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.00
P/B	0.00
Price/FCF	NM
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Apimeds Pharmaceuticals US, Inc. share price today?

Apimeds Pharmaceuticals US, Inc. (APUS) share price today is $1.23

Can Indians buy Apimeds Pharmaceuticals US, Inc. shares?

Yes, Indians can buy shares of Apimeds Pharmaceuticals US, Inc. (APUS) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in APUS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Apimeds Pharmaceuticals US, Inc. be purchased?

Yes, you can purchase fractional shares of Apimeds Pharmaceuticals US, Inc. (APUS) via the Vested app. You can start investing in Apimeds Pharmaceuticals US, Inc. (APUS) with a minimum investment of $1.

How to invest in Apimeds Pharmaceuticals US, Inc. shares from India?

You can invest in shares of Apimeds Pharmaceuticals US, Inc. (APUS) via Vested in three simple steps:

Click on Sign Up or Invest in APUS stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Apimeds Pharmaceuticals US, Inc. shares

What is Apimeds Pharmaceuticals US, Inc. 52-week high and low stock price?

The 52-week high price of Apimeds Pharmaceuticals US, Inc. (APUS) is $4.03. The 52-week low price of Apimeds Pharmaceuticals US, Inc. (APUS) is $1.05.

What is Apimeds Pharmaceuticals US, Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Apimeds Pharmaceuticals US, Inc. (APUS) is

What is Apimeds Pharmaceuticals US, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Apimeds Pharmaceuticals US, Inc. (APUS) is 0.00

What is Apimeds Pharmaceuticals US, Inc. dividend yield?

The dividend yield of Apimeds Pharmaceuticals US, Inc. (APUS) is 0.00%

What is the Market Cap of Apimeds Pharmaceuticals US, Inc.?

The market capitalization of Apimeds Pharmaceuticals US, Inc. (APUS) is $13.83M

What is Apimeds Pharmaceuticals US, Inc.'s stock symbol?

The stock symbol (or ticker) of Apimeds Pharmaceuticals US, Inc. is APUS

How Can Investors Use Apimeds Pharmaceuticals US, Inc. Share Price Data for Long-Term Investment Decisions?

Consider the share price of Apimeds Pharmaceuticals US, Inc. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Apimeds Pharmaceuticals US, Inc. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Apimeds Pharmaceuticals US, Inc. shares for Indian investors?

When investing in Apimeds Pharmaceuticals US, Inc. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Apimeds Pharmaceuticals US, Inc. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Apimeds Pharmaceuticals US, Inc. share price with other stocks in the same sector?

Rather than merely checking the share price of Apimeds Pharmaceuticals US, Inc. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Apimeds Pharmaceuticals US, Inc. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Apimeds Pharmaceuticals US, Inc. Share Price

Apimeds Pharmaceuticals US, Inc. Analyst Forecast

Apimeds Pharmaceuticals US, Inc. Share Price Chart

Apimeds Pharmaceuticals US, Inc. Key Stock Metrics

About Apimeds Pharmaceuticals US, Inc., Common Stock

Apimeds Pharmaceuticals US, Inc. Stock Returns

Apimeds Pharmaceuticals US, Inc. Financials

Apimeds Pharmaceuticals US, Inc. Ratios

Apimeds Pharmaceuticals US, Inc. Liquidity Ratios

Apimeds Pharmaceuticals US, Inc. Asset Efficiency Ratios

Apimeds Pharmaceuticals US, Inc. Liability Ratios

Apimeds Pharmaceuticals US, Inc. Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Apimeds Pharmaceuticals US, Inc. Share Price

Apimeds Pharmaceuticals US, Inc. Analyst Forecast

Apimeds Pharmaceuticals US, Inc. Share Price Chart

Apimeds Pharmaceuticals US, Inc. Key Stock Metrics

About Apimeds Pharmaceuticals US, Inc., Common Stock

Apimeds Pharmaceuticals US, Inc. Stock Returns

Apimeds Pharmaceuticals US, Inc. Financials

Apimeds Pharmaceuticals US, Inc. Ratios

Apimeds Pharmaceuticals US, Inc. Liquidity Ratios

Apimeds Pharmaceuticals US, Inc. Asset Efficiency Ratios

Apimeds Pharmaceuticals US, Inc. Liability Ratios

Apimeds Pharmaceuticals US, Inc. Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²